Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 919-927

  Gibbs, Bernhard F ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Ambroxol; Basophils; Bromhexine; Histamine; IgE; Signal transduction; Vasicine

Indexed keywords

AMBROXOL; BROMHEXINE; IMMUNOGLOBULIN E; MITOGEN ACTIVATED PROTEIN KINASE P38; MUCOLYTIC AGENT; SPUTOLYSIN; UNCLASSIFIED DRUG; VASICINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL; CELL ACTIVATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; ENZYME PHOSPHORYLATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 76349117881     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200407     Document Type: Article

References (29)

1. Lichtenstein LM, Bochner BS. The role of basophils in asthma. Ann NY Acad Sci 1991; 629:48-61.
2. Atkins PC, Schwartz LB, Adkinson NF, von Allmen, C, Valenzano M, Zweiman B. In vivo antigen induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 1990; 86:360-70.
3. st Century Renaissance of the Basophil? Current insights into their role in allergic responses and innate immunity. Exp Dermatol 2006; 15:855-64.
4. Devouassoux G, Foster B, Scott LM, Metcalfe DD, Prussin C. Frequency and characterization of antigenspecific IL-4- and IL-13-producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J Allergy Clin Immunol 1999; 104:811-9.
5. de Paulis A, Prevete N, Fiorentino I, et al. Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol 2006; 177:7322-31.
6. Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005; 23:191-202.
7. Obata K, Mukai K, Tsujimura Y, Ishiwata K, Kawano Y, Minegishi Y, Watanabe N, Karasuyama H. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 2007; 110:913-20.
8. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008; 9:310-8.
9. Kepley CL, McFeeley PJ, Oliver JM, Lipscomb MF. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med 2001; 164:1053-8.
10. Nouri-Aria KT, Irani AM, Jacobson MR, O'brien F, Varga EM, Till SJ, Durham SR, Schwartz LB. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol 2001; 108:205-11.
11. Gibbs BF, Schmutzler W, Vollrath IB, Brosthardt P, Braam U, Wolff HH, Zwadlo-Klarwasser G. Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res 1999; 48:86-93.
12. Gibbs BF, Wolff HH, Grabbe J. Ambroxol inhibits IgE-dependent mediator secretion from human skin mast cells. Inflamm Res 2000; 49(S):17-18.
13. Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol 2008; 4:1119-29.
14. Claeson UP, Malmfors T, Wikman G, Bruhn JG. Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol 2000; 72:1-20.
15. Haisch K, Gibbs BF, Körber H., Ernst M, Grage-Griebenow E, Schlaak M, Haas H. Purification of morphologically and functionally intact human basophils to near homogeneity. J Immunol Methods 1999; 226:129-37.
16. Gibbs BF, Plath KES, Wolff HH, Grabbe J. Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-Kinase inhibitors and calcium mobilization. J Leukocyte Biol 2002; 72:391-400.
17. Bechgaard E, Nielsen A. Bioavailability of bromhexine tablets and preliminary pharmacokinetics in humans. Biopharm Drug Dispos 1982; 3:337-44.
18. van Riemsdijk MM, van der Klauw MM, Strieker BH, Herings RM. Skin reactions attributed to the use of bromhexine. Ned Tijdschr Geneeskd 1994; 138:2446-8.
19. Beeh KM, Beier J, Esperester A, Paul LD. Antiinflammatory properties of ambroxol. Eur J Med Res 2008; 13:557-62.
20. Berni Canani M, De Luca L, Vuilleumier P, Berni Canani R. Study of the activity of ambroxol in children with aspecific bronchial hyperreactivity. Pediatr Med Chir 1987; 9:327-31.
21. Melillo G, Cocco G. Ambroxol decreases bronchial hyperreactivity. Eur J Respir Dis 1986; 69:316-20.
22. Fegiz G. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo. Lung 1991; 169:69-76.
23. Vytiska-Binstorfer E, Salzer H, Simbruner G. Ambroxol in comparison with betamethasone for the stimulation of antepartal lung maturity. A clinical double-blind study. Zentralbl Gynakol 1986; 108:220-9.
24. Mezzetti M, Colombo L, Marini GM, Crusi V, Pierfederici P, Mussini E. A pharmacorinetic study on pulmonary tropism of ambroxol in patients under thoracic surgery. J Em Surg Intensive Care 1990; 13:179-85.
25. Aerts NE, Dombrecht EJ, Bridts CH, Hagendorens MM, de Clerck LS, Stevens WJ, Ebo DG. Simultaneous flow cytometric detection of basophil activation marker CD63 and intracellular phosphorylated p38 mitogen-activated protein kinase in birch pollen allergy. Cytometry B Clin Cytom 2008; 76B:8-17.
26. Hasegawa I, Niisato N, Iwasaki Y, Marunaka Y. Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia. Biochem Biophys Res Commun 2006; 343:475-82.
27. Weiser T, Wilson N. Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxol. Mol Pharmacol 2002; 62:433-8.
28. Felix K, Pairet M, Zimmermann R. The antioxidative activity of the mucoregulatory agents: Ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study. Life Sci 1996; 59:1141-7.
29. Gillissen A, Scharling B, Jaworska M, Bartling A, Rasche K, Schultze-Werninghaus G. Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine AC. Res Exp Med (Berl) 1997; 196:389-98.